Skip to Content
200 Hawkins Drive
358 Medical Research Facility
Iowa City, Iowa 52242-2600
Phone: (319) 356-4848
The purpose of this study is to evaluate safety and how your body responds to an A/H5N8 flu vaccine alone and with two adjuvants called AS03 or MF59. An adjuvant is a substance that may cause the body to produce more antibodies when it is given with a vaccine. The influenza virus (a germ) or flu virus causes influenza or flu, an infection of your breathing tubes and your lungs. Several times in the past 100 years a new strain of flu virus has appeared. Because people had no resistance to these new strains, the illnesses were more severe, death rates were high even in healthy young adults, and worldwide spread of infection occurred. This worldwide spread is called a pandemic. In the past 18 years, flu viruses that at first only infected birds have begun to infect humans. One of
these strains, called avian influenza (A/H5N1 subtype) or "bird flu", has caused severe illness and death in several hundred people since late 2003. Scientists are worried that a "bird flu" virus could cause a pandemic. Over the last 18 months, a different "bird flu" virus (A/H5N8 subtype) has caused extensive outbreaks in domestic poultry and wild birds in South East Asia. In late 2014, "bird flu" viruses spread to Europe most likely via infected wild birds across migratory flyways causing outbreaks in poultry farms in several European countries, including Germany, the Netherlands, and the UK. The first appearance of these "bird flu" viruses in wild and domestic birds in the United States (US) was reported in December, 2014. As of June 17, 2015, the US Department of Agriculture (USDA) reported more than 48 million domestic birds in 15 states have been affected by the spread of these "bird flu" viruses. There are no laboratory-confirmed human infections with these "bird flu" viruses at this time. You are invited to participate in the study if you are in good health and between the ages of 19 and 64 years of age. The study lasts up to 13 months and there are 6 clinic visits and 6 phone calls. Compensation is provided. Please contact the Vaccine Research and Education Office at firstname.lastname@example.org or call 319-356-4848.
The University of Iowa Vaccine Research and Education unit is conducting a clinical trial on a Yellow Fever vaccine. The study will evaluate the safety and effectiveness of the study vaccine alone and with an adjuvant. An adjuvant is a substance that may cause the body to produce more antibodies when it is given with a vaccine. You are invited to participate in the study if you are 18 to 45 years old and in good health. The study lasts 13 months. There are 16 clinic visits and 4 phone calls. Blood is drawn at all of the clinic visits. Compensation is provided.Please contact the Vaccine Research and Education Office at email@example.com or call 319-356-4848.
University of Iowa is conducting a clinical trial on a new treatment for Bacterial Vaginosis (BV). The study is to see if a new vaginal gel is safe and effective. Women age 18 to 50 who have signs and symptoms of BV are invited to participate in this study. BV symptoms include unusual vaginal discharge and unpleasant smell. There are 3 study visits over a month period. Compensation is provided.To learn more, call 319-356-4848 or e-mail firstname.lastname@example.org.
Interested in hearing about our latest studies? Sign up to be a part of our registry. As a member of our registry, we will notify you of any studies we are doing that you may be eligible to participate in.
Simply complete this online registration form to become a member.
Copyright © 2015 The University of Iowa. All Rights Reserved.